|0.676||-0.068 / -9.14%|
Data as of 3:59pm ET
|0.6805||+0.0045 / +0.67%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +639.64% increase from the last price of 0.68.
The current consensus among 4 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.